2,651
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer

, , , , , , , , , , , & show all
Pages 747-757 | Received 17 Nov 2021, Accepted 05 May 2022, Published online: 03 Jun 2022